http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008103496-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00274
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00547
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-1475
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-1477
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-14
filingDate 2007-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4625d5a8b7f1ac51692010840b5cd5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d01f2ad53abadc5222cf460205a1902
publicationDate 2008-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2008103496-A1
titleOfInvention Neurostimulation Delivery During Transurethral Prostate Treatment
abstract In general, the invention provides a transurethral ablation device comprising an electrode for delivery of neurostimulation therapy to a patient to prevent or alleviate pain experienced during the course of a transurethral ablation procedure. The device may include a conductive ablation needle that delivers electrical current for ablation of prostate tissue, as well as neurostimulation current to prevent or alleviate pain encountered in response to the ablation current. In this sense, the ablation needle is integrated with a neurostimulation electrode. Alternatively, the device may incorporate a dedicated neurostimulation electrode independently of the ablation needle, either on the needle or on a catheter body that carries the needle.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8608664-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102124323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011190656-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792495-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11768269-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011270239-A1
priorityDate 2003-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6551300-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2001031941-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6852091-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676

Total number of triples: 30.